Literature DB >> 24876211

Streptococcus viridians bacteraemia and colonic adenocarcinoma.

Avenir Mulita1, Tokunbo Ajayi1.   

Abstract

Even though Streptococcus bacteraemia is an infrequent presentation of colonic malignancies, there is a well-established link between Streptococcus bovis bacteraemia and colonic malignancies. Most of the physicians are well aware of this correlation and further workup is pursued in most of the cases. However, many physicians may not be aware that other species of Streptococcus viridians, other than S. bovis, can be associated with colonic malignancies. In this case report, we present a case of Streptococcus viridians (anginosus) bacteraemia as a complication of an undiagnosed sigmoid adenocarcinoma. While further evidence is needed to warrant a gastrointestinal (GI) workup in a patient with other species of Streptococcus viridians bacteraemia, we would like to increase the awareness in the physicians' community regarding Streptococcus viridians, other than S. bovis bacteraemia. This would be especially relevant for patients who have no GI screening, as Streptococcus viridians bacteraemia can be an early sign of colonic neoplasm. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24876211      PMCID: PMC4039896          DOI: 10.1136/bcr-2014-203695

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Liver abscesses caused by Streptococcus milleri: an uncommon presenting sign of silent colonic cancer.

Authors:  Tomer Tzur; Sivan Liberman; Itamar Felzenstein; Ronit Cohen; Avraham I Rivkind; Gidon Almogy
Journal:  Isr Med Assoc J       Date:  2003-03       Impact factor: 0.892

2.  Enterococcal endocarditis associated with carcinoma of the sigmoid; report of a case.

Authors:  W C McCOY; J M MASON
Journal:  J Med Assoc State Ala       Date:  1951-12

Review 3.  Streptococcus sanguis bacteremia associated with cecal carcinoma: case report and review of the literature.

Authors:  M A Marinella
Journal:  Am J Gastroenterol       Date:  1997-09       Impact factor: 10.864

4.  Adenocarcinoma of the colon presenting as Streptococcus sanguis bacteremia.

Authors:  R Fass; A Alim; J D Kaunitz
Journal:  Am J Gastroenterol       Date:  1995-08       Impact factor: 10.864

5.  Streptococcus sanguis bacteremia and colorectal cancer: a case report.

Authors:  C E Kampe; T Vovan; A Alim; J Berenson
Journal:  Med Pediatr Oncol       Date:  1995-01

6.  Promotion of intestinal carcinogenesis by Streptococcus bovis.

Authors:  S Ellmerich; M Schöller; B Duranton; F Gossé; M Galluser; J P Klein; F Raul
Journal:  Carcinogenesis       Date:  2000-04       Impact factor: 4.944

7.  The association of Streptococcus bovis bacteremia and gastrointestinal diseases: a retrospective analysis.

Authors:  Waleed Alazmi; Manuel Bustamante; Colm O'Loughlin; Jeff Gonzalez; Jeffrey B Raskin
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

8.  Association of Streptococcus bovis bacteremia with colonic neoplasia and extracolonic malignancy.

Authors:  Jason S Gold; Sancar Bayar; Ronald R Salem
Journal:  Arch Surg       Date:  2004-07

9.  Streptococcus salivarius meningitis and colonic carcinoma.

Authors:  J F Legier
Journal:  South Med J       Date:  1991-08       Impact factor: 0.954

10.  Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis).

Authors:  Jordane Biarc; Isabelle S Nguyen; Annelise Pini; Francine Gossé; Sophie Richert; Danielle Thiersé; Alain Van Dorsselaer; Emmanuelle Leize-Wagner; Francis Raul; Jean-Paul Klein; Marie Schöller-Guinard
Journal:  Carcinogenesis       Date:  2004-01-23       Impact factor: 4.944

View more
  2 in total

1.  Second look at Streptococcus sanguinis and the colon.

Authors:  Robert Thomas; Vineet Gupta; Brian Kwan
Journal:  BMJ Case Rep       Date:  2018-06-29

2.  Metagenomic analysis of primary colorectal carcinomas and their metastases identifies potential microbial risk factors.

Authors:  Luigi Marongiu; Jonathan J M Landry; Tobias Rausch; Mohammed L Abba; Susanne Delecluse; Henri-Jacques Delecluse; Heike Allgayer
Journal:  Mol Oncol       Date:  2021-08-30       Impact factor: 6.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.